6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

  
3 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04919356
(ClinicalTrials.gov)		June 8, 20214/6/2021Parkinson's Disease G2019S LRRK2 Genetic Testing ProgramG2019S LRRK2 Parkinson's Disease: Increasing Awareness and Genetic Testing ProgramParkinson's DiseaseGenetic: G2019S LRRK2Escape Bio, Inc.Engage Health Inc.;SanoTerminated18 YearsN/AAll836United States
2NCT03279445
(ClinicalTrials.gov)		August 9, 201714/8/2017Parkinson's Disease in African American and Caucasian PatientsCharacteristics of African American People With Parkinson's Disease: A Hospital Based Study at the University of Chicago of the African American Community in Chicago's South SideParkinson DiseaseGenetic: Genetic testingUniversity of ChicagoNULLRecruiting15 Years100 YearsAll600United States
3NCT02668835
(ClinicalTrials.gov)		November 20154/12/2015GADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson's Disease TrialGADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson's Disease TrialParkinson Disease;Essential TremorDevice: Non intervention-Monitoring device;Genetic: Non intervention-Genetic testingScripps Translational Science InstituteMichael J. Fox Foundation for Parkinson's Research;Intel CorporationCompleted18 YearsN/AAll67NULL